BVXV - ビオンドバックス・ファ―マス―ティカルズ （BiondVax Pharmaceuticals Ltd.） ビオンドバックス・ファ―マス―ティカルズBVXVのチャート
BVXVの企業情報
| symbol | BVXV |
|---|---|
| 会社名 | BiondVax Pharmaceuticals Ltd （ビオンドバックス・ファ―マス―ティカルズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Biological Products (No Diagnostic Substances) |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- ビオンドバックス・ファ―マス―ティカルズは、イスラエルのバイオ医薬品企業。感染症の免疫調節療法に焦点をあて、臨床段階の医薬品の開発および実用化に従事。製品候補M-001は合成ペプチドベ―スのタンパク質で、季節的なインフルエンザウイルスと流行性インフルエンザウイルスの両方を標的に長期的な保護を提供するよう設計、開発を行う。 BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company focused on development and manufacturing of products for the prevention of infectious diseases. The Company had been developing M 001, a novel flu vaccine candidate that was designed to provide multi-strain and multi-season protection against current and future, seasonal and pandemic influenza. In seven Phase 1/2 and Phase 2 clinical trials designed to test for immunogenicity, the Company was able to demonstrate M-001 was effective in stimulating an immune response to a broad range of flu strains. In October 2020, the Company completed a Phase 3 clinical trial of M 001 which failed to meet the trial’s primary and secondary efficacy endpoints. The company is now pursuing opportunities in the infectious disease space, including exploring several alternatives for development of a pipeline of assets. |
| 本社所在地 | 14 Einstein Street Ness Ziona 74036 ISR |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 37803 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2015年 |
| 従業員数 | － |
| url | www.biondvax.com |
| nasdaq_url | https://www.nasdaq.com/symbol/bvxv |
| adr_tso | 5675763 |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 5.59 |
| 時価総額（marketcap） | 31727515.17 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
BVXVのテクニカル分析
BVXVのニュース
Companhia Energetica, Canopy Growth, Tilray Brands among premarket losers'' pack 2022/03/28 12:23:49 Seeking Alpha
Clever Leaves Holdings CLVR -20% after sharp rally last week.Companhia Energetica (CIG) -15%.BiondVax Pharmaceuticals BVXV -9% on FY earnings release.Enservco (ENSV) -8% announces…
Here''s Why Biondvax Pharmaceuticals Shares Are Rising 2022/03/24 15:48:03 Benzinga
Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV ) shares are trading higher by 32.1% at $1.81 after the company announced it signed a definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody therapies. BiondVax says the company is planning a rapid development path that leverages the company''s expertise and capabilities in biological drug development and manufacturing. BiondVax notes that … Full story available on Benzinga.com
BiondVax, Alpha Tau top healthcare gainers; Sonendo, Creative Medical among losers 2022/03/24 14:01:47 Seeking Alpha
BiondVax Pharmaceuticals BVXV +39%. Alpha Tau Medical (DRTS) +38%. Sonendo (SONX) -11%. Creative Medical Technology (CELZ) -9%.
94.93% Gain Drives BiondVax Pharmaceuticals Ltd. (BVXV) Into Becoming A Interest-Loosing Stock For Investors 2021/12/22 17:00:00 Marketing Sentinel
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) has a beta value of 2.26 and has seen 100.08 million shares traded in the recent trading session. The company, currently valued at $21.47M, closed the recent trade at $2.88 per share which meant it gained $1.4 on the day or 94.93% during that session. The BVXV stock price is -150.69% 94.93% Gain Drives BiondVax Pharmaceuticals Ltd. (BVXV) Into Becoming A Interest-Loosing Stock For Investors Read More »
BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pharma Soaring 2021/12/22 16:29:29 InvestorPlace
Biondvax Pharmaceuticals (BVXV) stock is on the rise Wednesday thanks to some positive news concerning its Covid-19 antibodies.
Companhia Energetica, Canopy Growth, Tilray Brands among premarket losers'' pack 2022/03/28 12:23:49 Seeking Alpha
Clever Leaves Holdings CLVR -20% after sharp rally last week.Companhia Energetica (CIG) -15%.BiondVax Pharmaceuticals BVXV -9% on FY earnings release.Enservco (ENSV) -8% announces…
Here''s Why Biondvax Pharmaceuticals Shares Are Rising 2022/03/24 15:48:03 Benzinga
Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV ) shares are trading higher by 32.1% at $1.81 after the company announced it signed a definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody therapies. BiondVax says the company is planning a rapid development path that leverages the company''s expertise and capabilities in biological drug development and manufacturing. BiondVax notes that … Full story available on Benzinga.com
BiondVax, Alpha Tau top healthcare gainers; Sonendo, Creative Medical among losers 2022/03/24 14:01:47 Seeking Alpha
BiondVax Pharmaceuticals BVXV +39%. Alpha Tau Medical (DRTS) +38%. Sonendo (SONX) -11%. Creative Medical Technology (CELZ) -9%.
94.93% Gain Drives BiondVax Pharmaceuticals Ltd. (BVXV) Into Becoming A Interest-Loosing Stock For Investors 2021/12/22 17:00:00 Marketing Sentinel
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) has a beta value of 2.26 and has seen 100.08 million shares traded in the recent trading session. The company, currently valued at $21.47M, closed the recent trade at $2.88 per share which meant it gained $1.4 on the day or 94.93% during that session. The BVXV stock price is -150.69% 94.93% Gain Drives BiondVax Pharmaceuticals Ltd. (BVXV) Into Becoming A Interest-Loosing Stock For Investors Read More »
BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pharma Soaring 2021/12/22 16:29:29 InvestorPlace
Biondvax Pharmaceuticals (BVXV) stock is on the rise Wednesday thanks to some positive news concerning its Covid-19 antibodies.
BiondVax Pharmaceuticals (NASDAQ:BVXV) Shares Cross Below Fifty Day Moving Average of $2.27 2021/11/10 08:46:46 Transcript Daily
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.27 and traded as low as $2.22. BiondVax Pharmaceuticals shares last traded at $2.26, with a volume of 61,958 shares traded. The stock has a 50 day moving []
BiondVax Pharmaceuticals (NASDAQ:BVXV) Stock Price Crosses Above 50-Day Moving Average of $2.33 2021/10/21 06:42:41 Transcript Daily
Shares of BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.33 and traded as high as $2.42. BiondVax Pharmaceuticals shares last traded at $2.39, with a volume of 64,771 shares changing hands. The company has a market capitalization []
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs 2021/10/08 11:31:17 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS ) Bicycle Therapeutics plc (NASDAQ: BCYC ) (announced interim Phase 1 data for BT5528 and preliminary results from Phase 1 study of BT8009) Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX ) Cytokinetics, Incorporated (NASDAQ: CYTK ) Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA ) Legend Biotech Corporation (NASDAQ: LEGN ) Click here for accessing Benzinga''s FDA Calendar Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 7) Acutus Medical, Inc. (NASDAQ: AFIB ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Amgen Inc. (NASDAQ: AMGN ) ( announced neurodegenerative disease drug collaboration with Nuemora) Angion Biomedica Corp. (NASDAQ: ANGN ) Applied DNA Sciences, Inc. (NASDAQ: APDN ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) ARCA biopharma, Inc. (NASDAQ: ABIO ) Avenue Therapeutics, Inc.